Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Kevin M, Belyk"'
Autor:
Andrew J. Neel, Zhuqing Liu, Tamas Benkovics, Lu Wang, Stephan M. Rummelt, Heather C. Johnson, Kevin M. Belyk, Feng Xu, Cheol K. Chung, David J. Lamberto, Ryan D. Cohen, Stephanus Axnanda, Zachary E. X. Dance
Publikováno v:
Organic Process Research & Development. 27:458-469
Autor:
Caitlin R. Lacker, Travis J. DeLano, Emily P. Chen, Jongrock Kong, Kevin M. Belyk, Tiffany Piou, Sarah E. Reisman
Publikováno v:
Journal of the American Chemical Society. 144:20190-20195
Autor:
Rebecca T. Ruck, Kevin M. Belyk, Robert P. Sheridan, Bangping Xiang, Katrina W. Lexa, Scott E. Denmark, Edward C. Sherer, Jeremy J. Henle
Publikováno v:
Organic Process Research & Development. 26:670-682
Molecular design benefits from a strong partnership between chemical intuition and machine learning. Given the proliferation of machine learning in the small molecule catalyst space, several ideas ...
Autor:
Caitlin R, Lacker, Travis J, DeLano, Emily P, Chen, Jongrock, Kong, Kevin M, Belyk, Tiffany, Piou, Sarah E, Reisman
Publikováno v:
Journal of the American Chemical Society. 144(44)
An asymmetric cross-coupling of α
Autor:
Xiaoxu Qi, Subramanian Jambu, Yining Ji, Kevin M. Belyk, Nihar R. Panigrahi, Paramjit S. Arora, Neil A. Strotman, Tianning Diao
Publikováno v:
Angewandte Chemie International Edition. 61
Radical addition to dehydroalanine (Dha) represents an appealing, modular strategy to access non-canonical peptide analogues for drug discovery. Prior studies on radical addition to the Dha residue of peptides and proteins have demonstrated outstandi
Autor:
Justin Belardi, Lushi Tan, Bangping Xiang, Nobuyoshi Yasuda, Ed Cleator, John S Edwards, Chen Frank, Lisa DiMichele, Kevin M. Belyk, Fabien L. Cabirol, Scott S. Ceglia, Jianguo Yin, Shen-Chun Kuo, Peter R Mullens, Weng Lin Tang, Adrian Goodyear, Guiquan Liu, Zhiguo Jake Song, Robert A. Reamer, Birgit Kosjek, Brian Bishop
Publikováno v:
Organic Process Research & Development. 21:1851-1858
The development of a scalable asymmetric route to a new calcitonin gene-related peptide (CGRP) receptor antagonist is described. The synthesis of the two key fragments was redefined, and the intermediates were accessed through novel chemistry. Chiral
Autor:
Robert A. Reamer, Jeffrey C. Moore, Stephen P. Keen, Lin Wang, Feng Peng, Billy Chen, Andrew W. Gibson, David R. Lieberman, David Murray, Kevin M. Belyk, Erika M. Milczek, Michael Williams, Ji Qi, Jongrock Kong, Lushi Tan, Mark McLaughlin, Zhiguo J. Song
Publikováno v:
Organic Letters. 19:926-929
An enantioselective synthesis of the potent anti-HIV nucleoside EFdA is presented. Key features of stereocontrol include construction of the fully substituted 4'-carbon via a biocatalytic desymmetrization of 2-hydroxy-2-((triisopropylsilyl)ethynyl)pr
Autor:
Hongming Li, R. Thomas Williamson, Edward C. Sherer, Andrew Brunskill, Kevin M. Belyk, Ian W. Davies, Louis-Charles Campeau, Rebecca T. Ruck, Katrina W. Lexa, Sumei Ren, Jingjun Yin, Qinghao Chen, Yining Ji, Alan M. Hyde
Publikováno v:
Chemical Science. 8:2841-2851
Significant catalyst loading reduction and increased reaction robustness have been achieved for a Pd-catalyzed asymmetric intramolecular C–N coupling through comprehensive mechanistic studies. Detailed kinetic, spectroscopic, and crystallographic a
Autor:
Danny Gauvreau, Guoyue Zhou, Chaozhan Gu, Louis-Charles Campeau, Wei Zhang, Qinghao Chen, Mélina Girardin, Lushi Tan, Kevin M. Belyk, Peter E. Maligres, Paul D. O’Shea
Publikováno v:
Organic Process Research & Development. 20:1476-1481
Doravirine is non-nucleoside reverse transcriptase inhibitor (NNRTI) currently in phase III clinical trials for the treatment of HIV infection. Herein we describe a robust kilo-scale synthesis for its manufacture. The structure and origin of major im
Autor:
Michael Shevlin, Melodie Christensen, Bangping Xiang, Michael R. Luzung, David M. Tschaen, Teresa Andreani, Stephen M. Dalby, Guy R. Humphrey, Zhiguo Jake Song, Kevin M. Belyk
Publikováno v:
Organic Process Research & Development. 20:1097-1103
The development of a concise asymmetric synthesis of the antiviral development candidate letermovir is reported, proceeding in >60% yield over a total of seven steps from commercially available materials. Key to the effectiveness of this process is a